Revenue ₹600 Cr
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Caplin Point Laboratories LtdCaplin Point delivered a strong FY26 with revenue doubling over five years to ₹2,300 crore and liquid assets tripling...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q4 FY26
15 May 2026
Revenue ₹600 Cr
Caplin Point delivered a strong FY26 with revenue doubling over five years to ₹2,300 crore and liquid assets tripling to ₹2,726 crore.
bullish
high
1 missed
Read full analysis →
Q3 FY26
10 Feb 2026
Revenue ₹543 Cr (+10.6% YoY)
Caplin Point reported a steady Q3 FY26 with 10.6% YoY revenue growth and 28.3% PAT margin, driven by strong US sterile injectable approvals and disciplined cost manage...
bullish
high
Scorecard starts after historical backfill
Read full analysis →